Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1262 press releases before 2023
-
Lokelma approved in Japan for the treatment of hyperkalaemia
-
AstraZeneca to discover and develop siRNA therapeutics for Cardiovascular, Renal, Metabolic and Respiratory diseases in new collaboration
-
AstraZeneca to donate 9 million face masks to support healthcare workers around the world in the fight against COVID-19
-
Lynparza granted orphan drug designation in Japan for BRCA-mutated metastatic pancreatic cancer
-
Imfinzi confirmed a sustained overall survival benefit in final analysis of the Phase III CASPIAN trial in 1st-line extensive-stage small cell lung cancer
-
Update on Phase III GY004 trial for cediranib added to Lynparza in platinum-sensitive relapsed ovarian cancer
-
Update on Phase III DANUBE trial for Imfinzi and tremelimumab in unresectable, Stage IV bladder cancer
-
AstraZeneca completes divestment agreement with Atnahs Pharma for established hypertension medicines
-
AstraZeneca divests global rights to Movantik
-
Full-year and Q4 2019 results
Latest articles and press releases
All of our latest press releases and articles are available to explore
Use a maximum of two downloads here
